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with polyethylene glycol-3350 reduces body weight and• Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R,
Bapat P, Kwun I, Shen CL. Novel insights of dietary polyphe-
nols and obesity. J Nutr Biochem 2014;25(1):1–18.
The prevalence of obesity has steadily increased over the
past 3 decades both in the United States and worldwide.
Recent studies have shown the role of dietary polyphe-
nols in the prevention of obesity and obesity-related chronic
diseases. Here, we evaluated the impact of commonly
consumed polyphenols, including green tea catechins, espe-
cially epigallocatechin gallates, resveratrol, and curcumin, on
obesity and obesity-related inﬂammation. Cellular studies
demonstrated that these dietary polyphenols reduce viabil-
ity of adipocytes and proliferation of preadipocytes, suppress
adipocyte differentiation and triglyceride accumulation, stim-
ulate lipolysis and fatty acid -oxidation, and reduce inﬂam-
mation. Concomitantly, the polyphenols modulate signaling
pathways including the adenosine-monophosphate-activated
protein kinase, peroxisome proliferator activated receptor ,
CCAAT/enhancer binding protein , peroxisome proliferator
activator receptor gamma activator 1-alpha, sirtuin 1, sterol
regulatory element binding protein-1c, uncoupling proteins
1 and 2, and nuclear factor-B that regulate adipogene-
sis as well as antioxidant and anti-inﬂammatory responses.
Animal studies strongly suggest that commonly consumed
polyphenols described in this review have a pronounced
effect on obesity as shown by lower body weight, fat mass,
and triglycerides through enhancing energy expenditure and
fat utilization, and modulating glucose hemostasis. Limited
human studies have been conducted in this area and are
inconsistent about the antiobesity impact of dietary polyphe-
nols probably due to the various study designs and lengths,
variation among patients (age, gender, ethnicity), chemical
forms of the dietary polyphenols used, and confounding
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2213-4220factors such as other weight-reducing agents. Future ran-
domized controlled trials are warranted to reconcile the
discrepancies between preclinical efﬁcacies and inconclusive
clinic outcomes of these polyphenols.
• Hu G, Zhang L, Rong Y, Ni X, Sun Y. Downstream car-
cinogenesis signaling pathways by green tea polyphenols:
a translational perspective of chemoprevention and treat-
ment for cancers. Curr Drug Metab 2014;15(1):14–22.
Green tea is one of the most popular beverages around the
world. For several decades, numerous epidemiological, pre-
clinical, and clinical studies have demonstrated that green
tea polyphenols (GTPs), especially epigallocatechin-3-gallate
(EGCG), have cancer-preventing effects on various cancers.
In this review, we present the inhibition of carcinogene-
sis in different animal models by GTPs or EGCG, including
prostate cancer, bladder cancer, breast cancer, intestinal can-
cer, colon cancer, gastric cancer, lung cancer, oral cancer,
and skin cancer. In vitro studies have shown that GTPs/EGCG
potently induces apoptosis and cell cycle arrest, and sup-
presses metastasis in tumor cells but not in their normal cell
counterparts. The molecular mechanisms of these activities
are discussed in detail to elucidate GTPs/EGCG down-
stream carcinogenesis signaling pathways and their values
from the perspective of chemoprevention and treatment for
cancers.
• Park JH, Choi YJ, Kim YW, Kim SP, Cho HC, Ahn S,
Bae KC, Im SS, Bae JH, Song DK. Green tea extractimproves glucose tolerance in db/db and high-fat diet
mice. Naunyn Schmiedebergs Arch Pharmacol 2013;386(8):
733–45.
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Green tea extract (GTE) is regarded to be effective against
besity and type 2 diabetes, but deﬁnitive lines of evidence
ave not been proven. Based on the assumption that the
allated catechins (GCs) in GTE attenuate intestinal glucose
nd lipid absorption,while enhancing insulin resistancewhen
Cs are present in the circulation through inhibiting cellu-
ar glucose uptake in various tissues, this study attempted
o block the intestinal absorption of GCs and prolong their
esidence time in the lumen. We then observed whether
TE containing the nonabsorbable GCs could ameliorate body
eight (BW) gain and glucose intolerance in db/db and high-
at diet mice. Inhibition of the intestinal absorption of GCs
as accomplished by coadministering the nontoxic polymer
olyethylene glycol-3350 (PEG). C57BLKS/J db/db and high-fat
iet C57BL/6 mice were treated for 4 weeks with drugs as
ollows: GTE, PEG, GTE+PEG, voglibose, or pioglitazone. GTE
ixed with meals did not have any ameliorating effects on
Wgain and glucose intolerance. However, the administration
f GTE plus PEG signiﬁcantly reduced BW gain, insulin resis-
ance, and glucose intolerance, without affecting food intake
nd appetite. The effect was comparable to the effects of an -
lucosidase inhibitor and a peroxisome proliferator-activated
eceptor-/ agonist. These results indicate that prolonging
he action of GCs of GTE in the intestinal lumen and block-
ng their entry into the circulation may allow GTE to be used
s a prevention and treatment for both obesity and obesity-
nduced type 2 diabetes.
Park JH, Kim SJ, Hwang I, Bae KC, Bae JH, Song DK. Green
tea extract coadministered with a polymer effectively pre-
vents alcoholic liver damage by prolonged inhibition of
alcohol absorption in mice. Alcohol Alcohol 2013;48(1):
59–67.
Aims: Alcohol toxicity can induce multiple organ dys-
unction, including the liver. Gallated catechins (GCs), the
omponents of green tea extract (GTE), have been known to
nhibit intestinal lipid absorption. This study was designed to
nvestigate the inhibitory effect of GC on the absorption of the
ipid-soluble ethanol in normal mice. In addition, the effec-
iveness of prolonging the GC-mediated effect was evaluated
s a means of preventing alcoholic liver damage.
Methods: GTE was administered orally immediately or
0minutes prior to ethanol administration and the blood
thanol and acetaldehyde levels were measured. Binge
thanol administration (by gavage every 6hours for 24hours)
as used to induce acute liver injury, and GTE was adminis-
ered 90minutes prior to every ethanol administration.
Results: When GTE, but not GC-decreased GTE, was admin-
stered immediately prior to ethanol intake, the blood ethanol39
and acetaldehyde levels were signiﬁcantly lower than those
in the control. By contrast, GTE has no effect when GTE
was administered 90minutes prior to ethanol intake. When
GTE was coadministered with polyethylene glycol (PEG) or
poly--glutamate (PGA) 90minutes prior to ethanol intake,
the lowering effect of GTE on the blood ethanol and
acetaldehyde levels was maintained in contrast to the GTE-
alone-treated group. After binge ethanol administration, liver
weight decreased, and serum alanine aminotransferase and
aspartate aminotransferase levelswere elevated. Additionally,
histopathological changes, such as macrovesicular steatosis
and necrosis, were induced in the liver, together with reactive
oxygen species generation. When GTE+PEG or GTE+PGA, but
not GTE alone, was administered 90minutes prior to ethanol
intake, acute liver injury was ameliorated.
Conclusion: These ﬁndings support the development of
GTE+PEG or GTE+PGA as an inhibitor of intestinal alcohol
absorption for the preventative treatment of acute alcohol tox-
icity.
• Park JH, Jin JY, Baek WK, Park SH, Sung HY, Kim YK, Lee J,
Song DK. Ambivalent role of gallated catechins in glucose
tolerance in humans: a novel insight into non-absorbable
gallated catechin-derived inhibitors of glucose absorption.
J Physiol Pharmacol 2009;60(4):101–9.
Prolongedpostprandial hyperglycemia is a detrimental fac-
tor for type 2 diabetes and obesity. The beneﬁt of green tea
extract (GTE) consumption still requires conﬁrmation. We
report the effects of circulating green tea catechins on blood
glucose and insulin levels. Oral glucose loading 1 hour after
GTE ingestion in humans led to higher blood glucose and
insulin levels than in control participants. Gallated catechins
were required for these effects, although within the intestinal
lumen they have been known to decrease glucose and choles-
terol absorption. Treatment with epigallocatechin-3-gallate
hindered 2-deoxyglucose uptake into liver, fat, pancreatic
beta cell, and skeletal muscle cell lines. The glucose intoler-
ance was ameliorated by gallated catechin-deﬁcient GTE or
GTE mixed with polyethylene glycol, which was used as an
inhibitor of intestinal absorption of gallated catechins. These
ﬁndings may suggest that the gallated catechin when it is in
the circulation elevates blood glucose level by blocking nor-
mal glucose uptake into the tissues, resulting in secondary
hyperinsulinemia, whereas it decreases glucose entry into the
circulation when they are inside the intestinal lumen. These
ﬁndings encourage the development of nonabsorbable deriva-
tives of gallated catechins for preventative treatment of type
2 diabetes and obesity, which would speciﬁcally induce only
the positive luminal effect.
